Tri-Screen Canine Lymphoma Test
Tri-Screen Canine Lymphoma Detection Assay System
A Unique New Tri-Partide Method Of Quickly And Accurately Differentiating Between Canine Lymphoma and Non-Malignant Lymphadenopathy
A New Tool in Lymphoma Differential Diagnosis Which Offers:
- 85% Sensitivity
- 93% Specificity
The Tri-Screen Canine Lymphoma Assay helps overcome the difficulties associated with the differential diagnosis of Canine Lymphoma and non-malignant lymphadenopathy resulting from infection, by providing a same day turnaround test which is able to differentiate between lymphadenopathy of non-malignant origin and lymphoma. Since the test requires only a small amount of blood, the test helps the vet make rapid decisions about diagnostic procedures and treatments when confronted with a dog exhibiting swollen lymph nodes.
Often lymphoma also presents in non-peripheral lymph nodes. Under these circumstances, other signs such as general malaise, hypercalcaemia or PU/PD indicate the disease. Furthermore, it is extremely difficult to biopsy the affected node in non -peripheral lymphoma. In these cases, the Tri-Screen Canine Lymphoma Assay provides the vet with a new, valuable tool to inform the decision on progressing to additional costly or invasive procedures.
The Tri-Screen Canine Lymphoma Diagnostic Kit represents a unique approach to the diagnosis of Canine Lymphoma. The kit is a three-part diagnostic system which utilizes assays for two acute phase proteins, Haptoglobin and CRP and then produces a diagnosis through the application of a patented algorithm to the Haptoglobin and CRP results which is accessed via the Tri-Screen.net website.
A PDF copy of the Tri-Screen Canine Lymphoma Assay Pack Insert and a copy of the poster which introduced the new assay at the Veterinary Cancer Society Conference in Albuquerque, USA in 2011 may be downloaded from the section on the right of this page.
Further information may be found on the dedicated Tri-Screen website by clicking on the Tri-Screen Logo below:
